Abstract
Biphenyl-2-yl-carbamic acid 1-{9-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro-quinolin-5-yl)-ethylamino]-nonyl}-piperidin-4-yl ester (THRX-198321) is a single molecule composed of a muscarinic acetylcholine receptor (mAChR) antagonist moiety, represented by the fragment MA, linked by a C9 polymethylene chain to a β2-adrenoceptor (β2AR) agonist moiety, represented by the fragment 8-hydroxy-5-((R)-1-hydroxy-2-methylamino-ethyl)-1H-quinolin-2-one (BA). THRX-198321 exhibited high affinity for mAChR (M2 pKI,App = 10.57 ± 0.09; M3 pKI,App = 10.07 ± 0.11) and β2AR (pKI,App = 9.54 ± 0.15), with potent mAChR antagonist (M2 pKI,Fn = 9.69 ± 0.23; M3 pKI,Fn = 10.05 ± 0.17) and β2AR agonist (pEC50 = 9.25 ± 0.02) activities. Consistent with multivalent interactions, THRX-198321 binding affinity was >300-fold higher at mAChR and 29-fold higher at β2AR relative to its monovalent fragments biphenyl carbamic acid piperidinyl ester (MA) and BA, respectively. THRX-198321 was a competitive antagonist at mAChR (M2 pKB = 9.98 ± 0.13; M3 pKB = 10.31 ± 0.89), whereas THRX-198321 agonist activity at β2AR was competitively inhibited by propranolol. Interactions of THRX-198321 with an allosteric site on mAChR and a novel extracellular allosteric site on β2AR, respectively, were detected by measuring THRX-198321-evoked changes in the dissociation rates for the orthosteric radioligands, [N-methyl-3H]scopolamine methyl chloride (M2 pEC50,diss = 6.73 ± 0.10; M3 pEC50,diss = 5.02 ± 0.14) and [4,6-propyl-3H]dihydroalprenolol (β2AR pEC50,diss = 3.82 ± 0.25). The carbostyril-linker fragment (BA-L) binds to the allosteric site of mAChR (M2 pEC50,diss = 5.06 ± 0.03; M3 pEC50,diss = 4.15 ± 0.25), whereas the MA fragment binds to the allosteric site of β2AR (pEC50,diss = 3.60 ± 0.18). Collectively, these observations suggest that THRX-198321 exhibits a multivalent bimodal orientation in the orthosteric and allosteric binding pockets of mAChR and β2AR, a phenomenon that may be unique to this class of molecule.
Footnotes
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.069120.
-
ABBREVIATIONS:
- β2AR
- β2-adrenoceptor
- mAChR
- muscarinic acetylcholine receptor
- MABA
- mAChR antagonist and β2AR agonist
- THRX-160209
- 4-{N-[7-(3-(S)-(1-carbamoyl-1,1-diphenylmethyl)pyrrolidin-1-yl)hept-1-yl]-N-(n-propyl)amino}-1-(2,6-dimethoxybenzyl)piperidine
- THRX-198321
- biphenyl-2-yl-carbamic acid 1-{9-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydro-quinolin-5-yl)-ethylamino]-nonyl}-piperidin-4-yl ester
- NMS
- N-methyl-scopolamine methyl chloride
- DHA
- 4,6-propyl-dihydroalprenolol
- W84
- 3-Methyl-5-[7-[4-[(4S)-4-methyl-1,3-oxazolidin-2-yl]phenoxy]heptyl]-1,2-oxazole
- MA
- biphenyl carbamic acid piperidinyl ester
- MA-L
- biphenyl-2-yl-carbamic acid 1-nonyl-piperidin-4-yl ester
- BA
- 8-hydroxy-5-((R)-1-hydroxy-2-methylamino-ethyl)-1H-quinolin-2-one
- BA-L
- 8-hydroxy-5-((R)-1-hydroxy-2-nonylamino-ethyl)-1H-quinolin-2-one
- HTRF
- homogeneous time-resolved fluorescence
- CHO
- Chinese hamster ovary
- HEK
- Human embryonic kidney
- PBS
- phosphate-buffered saline
- IP1
- myoinositol-1-phosphate
- GTPγS
- guanosine 5′-O-(3-thio)triphosphate
- BSA
- bovine serum albumin.
- Received September 29, 2010.
- Accepted December 7, 2010.
- Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|